Therapeutic persistence with infliximab was associated with signifi cantly fewer ulcerative colitis patients requiring hospitalization; once hospitalized, patients with therapeutic persistence had ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Omvoh (mirikizumab-mrkz) is a prescription drug that’s used to treat ulcerative colitis in adults. Omvoh comes as a liquid solution that’s given as an injection under your skin or as an intravenous ...
The Digestive Health Physicians Association issued a statement opposing CMS’ Most Favored Nation rule because it potentially limits access to infusion services. If the rule goes into effect, the ...
Dec. 3 (UPI) --Privately owned, standalone infusion centers are increasingly providing a comfortable and convenient alternative to hospitals and doctors' offices for people on prescribed medications ...
ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes in patients with ulcerative colitis previously untreated with a biologic, but the integrin receptor ...
Please provide your email address to receive an email when new articles are posted on . Among the top stories in gastroenterology last week were trial results that revealed patients who received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback